1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 28 results for "T-Cell Lymphoma (TCL)".

TCL - 002

A Rare Case of ALK-negative Anaplastic T-Cell Lymphoma Arising in a Prosthetic Knee Joint

Leena Alhusari

Poster Presenter: Leena Alhusari

Thumbnail for Laboratory Correlates and Response Patterns in Egyptian Patients With Mycosis Fungoides: A Cohort Analysis With LDH, NLR, and Two-Marker Rule

TCL - 054

Laboratory Correlates and Response Patterns in Egyptian Patients With Mycosis Fungoides: A Cohort Analysis With LDH, NLR, and Two-Marker Rule

Ahmed Ibrahim

Poster Presenter: Ahmed Ibrahim

$Thumbnail for Efficacy and Safety of Bispecific Antibodies in Relapsed/Refractory T-Cell Lymphoma: A Systematic Review and Single-Arm Meta-Analysis Focusing on Acimtamig (AFM13)$

SOHO 2026 Annual Meeting

Topics

A Rare Case of ALK-negative Anaplastic T-Cell Lymphoma Arising in a Prosthetic Knee Joint

Laboratory Correlates and Response Patterns in Egyptian Patients With Mycosis Fungoides: A Cohort Analysis With LDH, NLR, and Two-Marker Rule

Efficacy and Safety of Bispecific Antibodies in Relapsed/Refractory T-Cell Lymphoma: A Systematic Review and Single-Arm Meta-Analysis Focusing on Acimtamig (AFM13)

Serum Proteomics Reveals Immunoproteomic Profile Distinguishing Early-Stage Mycosis Fungoides From Atopic Dermatitis

Leukemia Subtype-Specific Patterns of Tumor Lysis Syndrome-Induced Acute Kidney Injury: Incidence, Dialysis Requirement, Mortality, and Healthcare Burden

Conditional Competing Causes of Death in 5-Year Survivors of Mycosis Fungoides: A SEER Population-Based Landmark Analysis

Real-World Outcomes of Secondary Hemophagocytic Lymphohistiocytosis in B-Cell Versus T/NK-Cell Lymphomas: A Propensity-Matched Study

Treatment of peripheral T-cell lymphoma with dose-dense, dose-intense chemotherapy as well as Avelumab and Brentuximab Vedutin

From Hodgkin Lymphoma to Thymoma: A Comprehensive Map of Second Primary Malignancy Risk in 14,765 CTCL Patients